PSMA PET scan

Solicite una Consulta
Imprimir

Departamentos y especialidades

Mayo Clinic tiene uno de los consultorios médicos más grandes y experimentados en los Estados Unidos, con campus en Arizona, Florida y Minnesota. El personal, que está capacitado en muchas especialidades, trabaja en conjunto para garantizar la atención de calidad y la recuperación exitosa.

Departamentos con pericia relacionada

Áreas que investigan este procedimiento

Investigación

Doctors and scientists at Mayo Clinic are studying ways to improve detection of metastatic prostate cancer and recurrent prostate cancer, including PSMA PET scans and other innovations in diagnostic testing.

Prostate cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

Publications

See a list of publications about prostate cancer PET scans by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

PSMA PET scan - atención en Mayo Clinic

Solicite una consulta
SobreAtención médica en Mayo Clinic
May 02, 2025
Imprimir
  1. Prostate cancer. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1459. Accessed March 18, 2025.
  2. Fact sheet: Molecular imaging and prostate cancer. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Fact-Sheets/Molecular-Imaging-and-Prostate-Cancer.aspx. Accessed March 31, 2025.
  3. PET/CT. RadiologyInfo.org. https://www.radiologyinfo.org/en/info/pet. Accessed March 24, 2025.
  4. Partin AW, et al., eds. Campbell-Walsh-Wein Urology. 12th ed. Elsevier; 2021. https://www.clinicalkey.com. Accessed March 24, 2025.
  5. Fendler WP, et al. PSMA PET/CT: Joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0. European Journal of Nuclear Medicine and Molecular Imaging. 2023; doi:10.1007/s00259-022-06089-w.
  6. Illuccix (prescribing information). Telix Pharmaceuticals; 2023. https://www.illuccix.com. Accessed March 31, 2025.
  7. Gozellix (prescribing information). Telix Pharmaceuticals; 2025. https://www.gozellix.com. Accessed March 31, 2025.
  8. Locametz (prescribing information). Novartis; 2023. https://www.locametz-hcp.com. Accessed March 31, 2025.
  9. Posluma (prescribing information). Blue Earth Diagnostics; 2024. https://www.posluma.com. Accessed March 31, 2025.
  10. Pylarify (prescribing information). Progenics Pharmaceuticals; 2023. https://www.pylarify.com. Accessed March 31, 2025.
  11. Taplin ME, et al. Initial staging and evaluation of males with newly diagnosed prostate cancer. https://www.uptodate.com/contents/search. Accessed March 31, 2025.
  12. Westphalen AC, et al. Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation. https://www.uptodate.com/contents/search. Accessed March 31, 2025.
  13. 177-Lu PSMA-617 therapy, (Pluvicto). Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Procedures/177Lu-PSMA-617-Therapy-Pluvicto.aspx. Accessed April 4, 2025.
  14. Radiation dose. Radiologyinfo.org. https://www.radiologyinfo.org/en/info/safety-xray. Accessed March 31, 2025.
  15. Voter AF, et al. A practical guide to the pearls and pitfalls of PSMA PET imaging. Seminars in Nuclear Medicine. 2023; doi:10.1053/j.semnuclmed.2023.11.001.
  16. Health Education & Content Services. About your PET/CT scan. Mayo Clinic; 2018.
  17. Health Education & Content Services. PET/MRI scan. Mayo Clinic; 2021.
  18. Nuclear medicine and radiation safety. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Patients/Patients/Fact-Sheets/Fact-Sheet--Nuclear-Medicine-and-Radiation-Safety.aspx. Accessed March 31, 2025.
  19. Choline C 11 Injection (approval letter). New Drug Application 203155. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203155. Accessed April 4, 2025.
  20. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  21. Harris KM. Allscripts EPSi. Mayo Clinic. April 23, 2024.
  22. Radiopharmaceutical therapy centers of excellence. Society of Nuclear Medicine and Molecular Imaging. https://snmmi.org/Web/Clinical-Practice/Radiopharmaceutical-Therapy-Centers-of-Excellence. Accessed March 31, 2025.

Relacionado

Noticias de Mayo Clinic

PSMA PET scan